Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HL08 Phase II in type 2 diabetes mellitus
CTR20241819Phase 2Completed
- Sponsor
- Hualan Biological Engineering Inc.
- Start
- May 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by Hualan Biological Engineering Inc.. Started May 2024; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20241819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241819.